Tabula Rasa HealthCare’s CareKinesis Signs Agreement with Total Life Healthcare
MOORESTOWN, N.J., June 13, 2018 — Tabula Rasa HealthCare (NASDAQ:TRHC) President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA announced TRHC subsidiary CareKinesis has been
TRHC Subsidiary CareKinesis Signs Agreement with SpiriTrust Lutheran LIFE
Moorestown, NJ (April 30, 2018) – CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, recently
Tabula Rasa HealthCare Subsidiary CareKinesis is Exclusive Provider of In-Home Medication Reminder Device for PACE Organizations
MOORESTOWN, N.J., April 16, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company that develops and employs medication risk mitigation software solutions and tools to optimize
Chief Pharmacotherapy Officer Robert L. Alesiani to Receive APhA’s Hugo H. Schaefer Award
Award recognizes outstanding voluntary contributions to the APhA, the profession and society MOORESTOWN, NJ, March 13, 2018, Tabula Rasa HealthCare, Inc., (“TRHC”) (NASDAQ: TRHC) announced
The Dangers of Polypharmacy in Elderly Patients
Jacques Turgeon, BPharm, PhD; Veronique Michaud, BPharm, PhD; Lauren Steffen, PharmD JAMA Intern Med. 2017;177(10):1544. doi:10.1001/jamainternmed.2017.4790 To the Editor In a recent issue of JAMA
TRHC and CareKinesis Host 18 PACE Medical Directors at 2017 Annual Clinical Advisory Panel Meeting: New Medication Risk Score Tops the Agenda
Moorestown NJ (September 28, 2017) – CareKinesis, a division of Tabula Rasa HealthCare (NASDAQ:TRHC), today announced it will be holding its 9th Clinical Advisory Panel
